Drug Class
RET kinase inhibitor
Type
brand
Active Ingredient
pralsetinib
📋Overview
Gavreto is a targeted cancer therapy known as a RET inhibitor. It is primarily associated with the treatment of certain types of cancers that have alterations in the RET gene, such as non-small cell lung cancer and some forms of thyroid cancer. By blocking abnormal RET signaling, Gavreto aims to slow or stop the growth of cancer cells. This medication is part of a newer class of drugs designed to address specific genetic changes in tumors.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Gavreto
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.